This site uses javascript. If javascript is disabled in your browser, some functionality may be impaired.
GLP-1 agonists are a family of peptides that have become popular in the early treatment of diabetes type ll.
A set of purification methods have been developed using Kromasil® stationary phases, including 100 Å diC4, for removal of impurities in peptide crudes.